These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21683461)

  • 21. Shortages of hospital registered nurses: causes and perspectives on public and private sector actions.
    Buerhaus PI
    Nurs Outlook; 2002; 50(1):4-6. PubMed ID: 12026882
    [No Abstract]   [Full Text] [Related]  

  • 22. South Africa--blazing a trail for African biotechnology.
    Motari M; Quach U; Thorsteinsdóttir H; Martin DK; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC37-41. PubMed ID: 15583683
    [No Abstract]   [Full Text] [Related]  

  • 23. Private health care sector investment in Brazil: opportunities and obstacles.
    Brandt R
    World Hosp Health Serv; 2003; 39(1):11-4, 30, 32. PubMed ID: 12743882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in public and private sector adoption of telemedicine: Indian case study for sectoral adoption.
    Sood SP; Negash S; Mbarika VW; Kifle M; Prakash N
    Stud Health Technol Inform; 2007; 130():257-68. PubMed ID: 17917199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Provider diversity in the English NHS: a study of recent developments in four local health economies.
    Allen P; Turner S; Bartlett W; Perotin V; Matchaya G; Zamora B
    J Health Serv Res Policy; 2012 Jan; 17 Suppl 1():23-30. PubMed ID: 21890683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 27. Being sucessfully disruptive.
    Hogan J
    Med Device Technol; 2005 Jun; 16(5):21, 23. PubMed ID: 15984542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emergence of Egyptian biotechnology from generics.
    Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
    [No Abstract]   [Full Text] [Related]  

  • 29. The socio-economic landscape of biotechnology in Spain. A comparative study using the innovation system concept.
    Díaz V; Muñoz E; de los Monteros JE; Senker J
    J Biotechnol; 2002 Sep; 98(1):25-40. PubMed ID: 12126803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biomedical research: private interests and public interests].
    Martin J
    Sante Publique; 2001 Mar; 13(1):89-93. PubMed ID: 11525046
    [No Abstract]   [Full Text] [Related]  

  • 32. The anatomy of medical research: US and international comparisons.
    Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
    JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovation and the English National Health Service: a qualitative study of the independent sector treatment centre programme.
    Turner S; Allen P; Bartlett W; Pérotin V
    Soc Sci Med; 2011 Aug; 73(4):522-529. PubMed ID: 21782302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Need to Knowledge (NtK) Model: an evidence-based framework for generating technological innovations with socio-economic impacts.
    Flagg JL; Lane JP; Lockett MM
    Implement Sci; 2013 Feb; 8():21. PubMed ID: 23414369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drug discovery: extraordinary opportunities in an uncertain time.
    Kinch MS; Flath R
    Drug Discov Today; 2015 Nov; 20(11):1288-92. PubMed ID: 25528676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Financial anatomy of biomedical research.
    Moses H; Dorsey ER; Matheson DH; Thier SO
    JAMA; 2005 Sep; 294(11):1333-42. PubMed ID: 16174691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crowdsourcing biomedical research: leveraging communities as innovation engines.
    Saez-Rodriguez J; Costello JC; Friend SH; Kellen MR; Mangravite L; Meyer P; Norman T; Stolovitzky G
    Nat Rev Genet; 2016 Jul; 17(8):470-86. PubMed ID: 27418159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing the public-private mix to achieve universal health coverage.
    McPake B; Hanson K
    Lancet; 2016 Aug; 388(10044):622-30. PubMed ID: 27358252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.